David F. Ransohoff

31.3k total citations · 9 hit papers
154 papers, 17.9k citations indexed

About

David F. Ransohoff is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Pathology and Forensic Medicine. According to data from OpenAlex, David F. Ransohoff has authored 154 papers receiving a total of 17.9k indexed citations (citations by other indexed papers that have themselves been cited), including 81 papers in Oncology, 52 papers in Pulmonary and Respiratory Medicine and 42 papers in Pathology and Forensic Medicine. Recurrent topics in David F. Ransohoff's work include Colorectal Cancer Screening and Detection (71 papers), Genetic factors in colorectal cancer (41 papers) and Gastric Cancer Management and Outcomes (40 papers). David F. Ransohoff is often cited by papers focused on Colorectal Cancer Screening and Detection (71 papers), Genetic factors in colorectal cancer (41 papers) and Gastric Cancer Management and Outcomes (40 papers). David F. Ransohoff collaborates with scholars based in United States, United Kingdom and Australia. David F. Ransohoff's co-authors include Alvan R. Feinstein, Thomas F. Imperiale, Douglas G. Altman, Ewout W. Steyerberg, Petra Macaskill, Andrew J. Vickers, Johannes B. Reitsma, Gary S. Collins, Karel G.M. Moons and John P. A. Ioannidis and has published in prestigious journals such as New England Journal of Medicine, JAMA and Journal of Clinical Oncology.

In The Last Decade

David F. Ransohoff

148 papers receiving 17.2k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): Explanation and Elaboration

2015 3.1k citations Karel G.M. Moons, Douglas G. Altman et al. Annals of Internal Medicine profile →
Dysplasia in inflammatory bowel disease: Standardized classification with provisional clinical applications

1983 1.4k citations David F. Ransohoff et al. profile →
Problems of Spectrum and Bias in Evaluating the Efficacy of Diagnostic Tests

1978 1.3k citations David F. Ransohoff et al. New England Journal of Medicine profile →
Multitarget Stool DNA Testing for Colorectal-Cancer Screening

2014 1.3k citations Thomas F. Imperiale, David F. Ransohoff et al. New England Journal of Medicine profile →
Risk of Advanced Proximal Neoplasms in Asymptomatic Adults According to the Distal Colorectal Findings

2000 766 citations Thomas F. Imperiale, Gregory N. Larkin et al. New England Journal of Medicine profile →
Fecal DNA versus Fecal Occult Blood for Colorectal-Cancer Screening in an Average-Risk Population

2004 588 citations Thomas F. Imperiale, David F. Ransohoff et al. New England Journal of Medicine profile →
Prospective evaluation of methylated SEPT9 in plasma for detection of asymptomatic colorectal cancer

2013 575 citations Timothy R. Church, Michael Wandell et al. profile →
The Natural History of Silent Gallstones

1982 391 citations William A. Gracie, David F. Ransohoff New England Journal of Medicine profile →
Addressing overdiagnosis and overtreatment in cancer: a prescription for change

2014 351 citations David F. Ransohoff et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
David F. Ransohoff United States	55	8.1k	6.3k	4.4k	3.9k	2.1k	154	17.9k
Benjamin F. Hankey United States	39	9.5k 1.2×	5.3k 0.8×	2.9k 0.7×	2.4k 0.6×	2.4k 1.1×	76	18.0k
Benny Zee Hong Kong	73	9.8k 1.2×	6.0k 0.9×	6.0k 1.4×	1.9k 0.5×	3.5k 1.6×	324	23.2k
J. Hermans Netherlands	78	5.2k 0.6×	7.8k 1.2×	4.9k 1.1×	2.4k 0.6×	1.8k 0.8×	338	20.8k
Valter Torri Italy	66	8.8k 1.1×	7.2k 1.1×	3.8k 0.9×	2.7k 0.7×	1.7k 0.8×	305	21.2k
Donald E. Henson United States	55	7.1k 0.9×	3.5k 0.5×	4.4k 1.0×	3.2k 0.8×	1.9k 0.9×	223	14.2k
Phyllis A. Wingo United States	52	9.4k 1.2×	4.9k 0.8×	3.0k 0.7×	2.3k 0.6×	2.3k 1.1×	105	20.8k
Kimberly Andrews United States	21	9.1k 1.1×	4.0k 0.6×	1.7k 0.4×	2.9k 0.7×	1.8k 0.8×	28	14.9k
Fabio Levi Switzerland	81	10.0k 1.2×	4.5k 0.7×	4.4k 1.0×	2.8k 0.7×	4.1k 1.9×	456	24.5k
Steven Piantadosi United States	88	11.1k 1.4×	10.1k 1.6×	4.6k 1.0×	2.9k 0.7×	2.1k 1.0×	259	30.5k
Limin X. Clegg United States	31	6.6k 0.8×	3.7k 0.6×	2.7k 0.6×	1.2k 0.3×	2.2k 1.0×	44	16.7k

Countries citing papers authored by David F. Ransohoff

Since Specialization

Citations

This map shows the geographic impact of David F. Ransohoff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David F. Ransohoff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David F. Ransohoff more than expected).

Fields of papers citing papers by David F. Ransohoff

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David F. Ransohoff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David F. Ransohoff. The network helps show where David F. Ransohoff may publish in the future.

Co-authorship network of co-authors of David F. Ransohoff

This figure shows the co-authorship network connecting the top 25 collaborators of David F. Ransohoff. A scholar is included among the top collaborators of David F. Ransohoff based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David F. Ransohoff. David F. Ransohoff is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Skarlupka, Amanda L., Christos Patriotis, Wendy S. Rubinstein, et al.. (2025). Framework to Select Multi-Cancer Detection Assays in the National Cancer Institute’s Vanguard Study. Cancer Epidemiology Biomarkers & Prevention. 34(10). 1787–1793.

Moons, Karel G.M., Douglas G. Altman, Johannes B. Reitsma, et al.. (2023). Transparent Reporting of a Multivariable Prediction Model for Individual Prognosis or Diagnosis (TRIPOD): Explanation and Elaboration. Translation into Russian. SHILAP Revista de lepidopterología. 22(2). 109–187. 1 indexed citations

Moons, Karel G.M., Douglas G. Altman, Johannes B. Reitsma, et al.. (2022). Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): Explanation and Elaboration. Translation in to Russian. SHILAP Revista de lepidopterología. 3(3). 232–322. 3 indexed citations

Gunter, Marc J., Samar Alhomoud, Melina Arnold, et al.. (2019). Meeting report from the joint IARC–NCI international cancer seminar series: a focus on colorectal cancer. Annals of Oncology. 30(4). 510–519. 51 indexed citations

Jodal, Henriette C., Magnus Løberg, Øyvind Holme, et al.. (2018). Mortality From Postscreening (Interval) Colorectal Cancers Is Comparable to That From Cancer in Unscreened Patients—A Randomized Sigmoidoscopy Trial. Gastroenterology. 155(6). 1787–1794.e3. 7 indexed citations

Imperiale, Thomas F., Patrick O. Monahan, Timothy E. Stump, Elizabeth A. Glowinski, & David F. Ransohoff. (2015). Derivation and Validation of a Scoring System to Stratify Risk for Advanced Colorectal Neoplasia in Asymptomatic Adults: A Cross-sectional Study. Carolina Digital Repository (University of North Carolina at Chapel Hill). 9 indexed citations

Payne, Shannon R., Timothy R. Church, Michael Wandell, et al.. (2013). Endoscopic Detection of Proximal Serrated Lesions and Pathologic Identification of Sessile Serrated Adenomas/Polyps Vary on the Basis of Center. Clinical Gastroenterology and Hepatology. 12(7). 1119–1126. 117 indexed citations

Ransohoff, David F.. (2013). Cultivating Cohort Studies for Observational Translational Research. Cancer Epidemiology Biomarkers & Prevention. 22(4). 481–484. 5 indexed citations

Hayes, Daniel F., Jeff Allen, Carolyn C. Compton, et al.. (2013). Breaking a Vicious Cycle. Science Translational Medicine. 5(196). 196cm6–196cm6. 90 indexed citations

10.

Imperiale, Thomas F., Elizabeth A. Glowinski, Beth E. Juliar, Faouzi Azzouz, & David F. Ransohoff. (2009). Variation in polyp detection rates at screening colonoscopy. Gastrointestinal Endoscopy. 69(7). 1288–1295. 100 indexed citations

11.

Imperiale, Tom, Elizabeth A. Glowinski, Gregory N. Larkin, et al.. (2009). Five-Year risk of colorectal neoplasia after negative screening colonoscopy. Acta Endoscopica. 39(2). 114–115. 3 indexed citations

12.

Imperiale, Thomas F., David F. Ransohoff, Steven H. Itzkowitz, Barry A. Turnbull, & Michael E. Ross. (2004). Fecal DNA versus Fecal Occult Blood for Colorectal-Cancer Screening in an Average-Risk Population. New England Journal of Medicine. 351(26). 2704–2714. 588 indexed citations breakdown →

13.

Cohen, Sidney, Bruce R. Bacon, Jesse A. Berlin, et al.. (2002). National Institutes of Health State-of-the-Science Conference Statement: ERCP for diagnosis and therapy, January 14-16, 2002. Gastrointestinal Endoscopy. 56(6). 803–809. 167 indexed citations

14.

Macrae, Finlay, et al.. (1997). Colorectal cancer screening: Clinical guidelines and rationale (multiple letters). Gastroenterology. 113(4). 1422–1424. 1 indexed citations

15.

Ransohoff, David F. & Russell Harris. (1997). Lessons from the Mammography Screening Controversy: Can We Improve the Debate?. Annals of Internal Medicine. 127(11). 1029–1034. 50 indexed citations

16.

Ransohoff, David F.. (1995). Why are cholecystectomy rates increasing?. JAMA. 273(20). 1621–1622. 4 indexed citations

17.

Ransohoff, David F. & William A. Gracie. (1990). Management of patients with symptomatic gallstones: A quantitative analysis. The American Journal of Medicine. 88(2). 154–160. 29 indexed citations

18.

King, Charles H., Ruth M. Greenblatt, Sally Hodder, et al.. (1988). Chemotherapy-Based Control of Schistosomiasis haematobia. I. Metrifonate Versus Praziquantel in Control of Intensity and Prevalence of Infection. American Journal of Tropical Medicine and Hygiene. 39(3). 295–305. 69 indexed citations

19.

Littenberg, Benjamin & David F. Ransohoff. (1984). Three Decision Strategies for the Individual. 1 indexed citations

20.

Ransohoff, David F.. (1981). Real-time ultrasonography in the diagnosis of gallbladder disease. Gastroenterology. 80(4). 872–873. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact